{"id":"W2596676407","doi":"10.1056/nejmoa1614062","title":"Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Internal medicine; PCSK9; Placebo; Hazard ratio; Cholesterol; Apolipoprotein B; Evolocumab; Gastroenterology; Hyperlipidemia; Endocrinology; Confidence interval; Lipoprotein; Apolipoprotein A1; LDL receptor; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002417742,0.0001173518,0.0005043107,0.00009620904,0.0001993529,0.00002617923,0.00008120853,0.00005991319,0.00003987465],"category_scores_gemma":[0.000482272,0.00006484154,0.00006672353,0.00004787502,0.0001555541,0.0003476094,0.00001743251,0.0003064366,0.000001033943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005025751,"about_ca_system_score_gemma":0.0001989136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002505676,"about_ca_topic_score_gemma":0.00001102072,"domain_scores_codex":[0.9987088,0.00008830263,0.0003832499,0.0001183112,0.0005518172,0.0001495389],"domain_scores_gemma":[0.9985023,0.00003370546,0.0004681329,0.0004128793,0.000274469,0.0003085772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002700236,0.0001101084,0.02374492,0.0004285916,0.0004261071,0.0002062572,0.001849289,0.000008043742,0.007701602,0.0003305829,0.00181942,0.9606748],"study_design_scores_gemma":[0.1805876,0.008730877,0.6370901,0.002753548,0.001958849,0.0531912,0.0008748787,0.0002791257,0.002573318,0.001244513,0.110395,0.000321003],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730161,0.0006393489,0.008423376,0.01498822,0.0005325917,0.00028797,7.916099e-7,0.00001048004,0.002101124],"genre_scores_gemma":[0.9905049,0.001050727,0.00121626,0.0001107246,0.006980882,8.533546e-7,0.000004894234,0.00001080101,0.0001199939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9603539,"threshold_uncertainty_score":0.2644162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01550424384651158,"score_gpt":0.2962377380739194,"score_spread":0.2807334942274078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}